kiropraktorerne.com ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.0% 4.2% 1.9% 1.6% 1.9%  
Credit score (0-100)  59 48 69 74 69  
Credit rating  BBB BBB A A A  
Credit limit (kDKK)  0.0 0.0 0.7 5.1 0.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  2,276 1,917 2,642 2,844 2,725  
EBITDA  363 23.8 469 621 573  
EBIT  -12.2 -264 197 342 348  
Pre-tax profit (PTP)  17.7 -219.9 254.7 337.8 362.4  
Net earnings  6.3 -172.8 194.7 262.9 272.2  
Pre-tax profit without non-rec. items  17.7 -220 255 338 362  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  228 181 109 88.8 52.3  
Shareholders equity total  1,707 1,535 1,729 1,992 764  
Interest-bearing liabilities  1,035 2,218 2,020 165 395  
Balance sheet total (assets)  3,678 4,586 4,445 3,062 2,098  

Net Debt  982 2,090 1,909 59.0 276  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,276 1,917 2,642 2,844 2,725  
Gross profit growth  -12.3% -15.8% 37.8% 7.7% -4.2%  
Employees  4 4 4 4 4  
Employee growth %  -20.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,678 4,586 4,445 3,062 2,098  
Balance sheet change%  1.0% 24.7% -3.1% -31.1% -31.5%  
Added value  363.4 23.8 468.7 613.9 572.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -667 -535 -544 -499 -461  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 1.0 2.0 3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -0.5% -13.8% 7.5% 12.0% 12.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  1.7% -3.5% 7.3% 12.4% 16.2%  
ROI %  2.0% -4.1% 8.5% 15.2% 24.4%  
ROE %  0.4% -10.7% 11.9% 14.1% 19.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  46.4% 33.5% 38.9% 65.1% 36.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  270.3% 8,797.2% 407.2% 9.5% 48.2%  
Gearing %  60.6% 144.5% 116.8% 8.3% 51.7%  
Net interest  0 0 0 0 0  
Financing costs %  4.1% 4.8% 3.6% 11.6% 20.1%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.4 1.2 1.4 2.6 1.4  
Current Ratio  1.4 1.2 1.4 2.6 1.4  
Cash and cash equivalent  52.8 127.7 111.5 106.5 119.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  614.6 719.7 1,140.6 1,583.0 549.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  91 6 117 153 143  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  91 6 117 155 143  
EBIT / employee  -3 -66 49 85 87  
Net earnings / employee  2 -43 49 66 68